Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Age-Related Macular Degeneration
20081.1k citationsWilliam F. Mieler et al.profile →
Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)
2016738 citationsWilliam F. Mieler et al.profile →
Revised Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy
2011447 citationsWilliam F. Mieler et al.profile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by William F. Mieler
Since
Specialization
Citations
This map shows the geographic impact of William F. Mieler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William F. Mieler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William F. Mieler more than expected).
Fields of papers citing papers by William F. Mieler
This network shows the impact of papers produced by William F. Mieler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William F. Mieler. The network helps show where William F. Mieler may publish in the future.
Co-authorship network of co-authors of William F. Mieler
This figure shows the co-authorship network connecting the top 25 collaborators of William F. Mieler.
A scholar is included among the top collaborators of William F. Mieler based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with William F. Mieler. William F. Mieler is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Kang‐Mieler, Jennifer J., Soo-Hyun Kim, Wenqiang Liu, et al.. (2018). Aflibercept-loaded Microsphere-hydrogel Drug Delivery System in a Nonhuman Primate Model. Investigative Ophthalmology & Visual Science. 59(9). 3265–3265.2 indexed citations
7.
Liu, Wenqiang, et al.. (2018). Efficacy of a Biodegradable Aflibercept-loaded Microsphere-Hydrogel Drug Delivery System in a Laser-induced Choroidal Neovascularization Rat Model. Investigative Ophthalmology & Visual Science. 59(9). 3262–3262.1 indexed citations
8.
Dikopf, Mark S., et al.. (2013). Treatment of Radiation Maculopathy with Bevacizumab versus Alternating Bevacizumab and Intravitreal Triamcinolone. Investigative Ophthalmology & Visual Science. 54(15). 3841–3841.2 indexed citations
9.
Jiang, Bin, et al.. (2011). PLGA Nanospheres Encapsulated Within Thermo-responsive Hydrogel For Ocular Delivery Of Dexamethasone Sodium Phosphate. Investigative Ophthalmology & Visual Science. 52(14). 467–467.1 indexed citations
Mieler, William F., et al.. (2007). Synthetic Melanin as a Photoprotector Against Radical Oxygen Species. Investigative Ophthalmology & Visual Science. 48(13). 5955–5955.1 indexed citations
12.
Alexandrou, T. J., Seenu M. Hariprasad, William F. Mieler, et al.. (2006). Elimination of Conjunctival Bacterial Flora With the Use of Mupirocin Nasal Ointment. Investigative Ophthalmology & Visual Science. 47(13). 1492–1492.1 indexed citations
13.
Regillo, Carl D., et al.. (2005). Safety Outcomes of Clinical Studies for Anecortave Acetate in Patients With Exudative Age–Related Macular Degeneration (AMD). Investigative Ophthalmology & Visual Science. 46(13). 1373–1373.2 indexed citations
14.
Chévez‐Barrios, Patricia, Ann M. Leen, Murali Chintagumpala, et al.. (2005). Immune Response of Retinoblastoma Treated With Suicide Gene Therapy Using Adenoviral–Mediated Delivery of Thymidine Kinase Followed by Ganciclovir. Investigative Ophthalmology & Visual Science. 46(13). 5218–5218.1 indexed citations
15.
Westfall, Andrew C., April Y. Maa, William F. Mieler, & Eric R. Holz. (2004). Incidence of Retinal Tears and Late–onset Retinal Breaks in Eyes with a Symptomatic Posterior Vitreous Detachment. Investigative Ophthalmology & Visual Science. 45(13). 2066–2066.1 indexed citations
16.
Font, R. L., Kirtee Rishi, William F. Mieler, & Patricia Chévez‐Barrios. (2004). Clinical, Cytological And Immunophenotypical Characteristics Of Primary Lymphoma Of Retina And Vitreous. An Analysis Of 20 Cases.. Investigative Ophthalmology & Visual Science. 45(13). 1228–1228.4 indexed citations
17.
Mieler, William F., et al.. (2003). Scleral Buckling in Stage 4 Retinopathy of Prematurity with Significant Vitreoretinal Traction. Investigative Ophthalmology & Visual Science. 44(13). 603–603.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.